FDA advisory panel recommends use of Merck's COVID-19 pill

The Merck logo.
(Image credit: AP Photo/Mel Evans, File)

The Food and Drug Administration's Antimicrobial Drugs Advisory Committee voted on Tuesday to recommend emergency authorization of molnupiravir, Merck's oral COVID-19 treatment pill.

It was a narrow vote of 13-10, and some panel members said that after they weighed the risks and benefits, they felt there were still too many unanswered questions about the pill's safety and whether it could enable the virus to mutate into variants that can get around current vaccines, CNBC reports.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
Explore More
Catherine Garcia, The Week US

Catherine Garcia has worked as a senior writer at The Week since 2014. Her writing and reporting have appeared in Entertainment Weekly, The New York Times, Wirecutter, NBC News and "The Book of Jezebel," among others. She's a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.